Table 2.
Annual Incidence of Active Exudative Age-related Macular Degeneration, 2011–2018
| Year | Incidence |
Incidence Rate (95% CI) |
Mean Age (±SD) |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Men | Women | Total | Men | Women | Total | Men | Women | Total | |
| 2011 | 10 700 | 5711 | 16 411 | 31.22 (30.62–31.81) | 14.75 (14.37–15.14) | 22.49 (22.14–22.83) | 72.46 ± 9.93 | 73.17 ± 10.16 | 72.70 ± 10.01 |
| 2012 | 14 057 | 7507 | 21 564 | 40.58 (39.91–41.25) | 19.21 (18.77–19.64) | 29.25 (28.86–29.64) | 72.53 ± 10.01 | 73.47 ± 10.14 | 72.86 ± 10.07 |
| 2013 | 17 407 | 10 808 | 28 215 | 49.73 (48.99–50.47) | 27.39 (26.87–27.90) | 37.89 (37.45–38.33) | 72.53 ± 10.14 | 73.41 ± 10.23 | 72.87 ± 10.18 |
| 2014 | 20 723 | 13 865 | 34 588 | 58.62 (57.82–59.41) | 34.82 (34.24–35.40) | 46.01 (45.52–46.49) | 72.04 ± 10.40 | 73.25 ± 10.45 | 72.52 ± 10.43 |
| 2015 | 21 464 | 14 014 | 35 478 | 59.96 (59.16–60.76) | 34.90 (34.32–35.47) | 46.71 (46.22–47.19) | 72.37 ± 10.53 | 73.64 ± 10.48 | 72.87 ± 10.53 |
| 2016 | 21 298 | 13 843 | 35 141 | 59.08 (58.28–59.87) | 34.25 (33.68–34.82) | 45.95 (45.47–46.43) | 72.59 ± 10.69 | 74.04 ± 10.51 | 73.16 ± 10.64 |
| 2017 | 22 609 | 14 646 | 37 255 | 62.38 (61.57–63.19) | 36.06 (35.48–36.64) | 48.47 (47.98–48.97) | 72.58 ± 10.79 | 74.39 ± 10.61 | 73.29 ± 10.76 |
| 2018 | 22 771 | 14 641 | 37 412 | 62.56 (61.75–63.38) | 35.91 (35.33–36.49) | 48.48 (47.99–48.97) | 72.92 ± 10.86 | 75.03 ± 10.57 | 73.75 ± 10.80 |
| Total | 151 029 | 95 035 | 246 064 | 53.22 (52.95–53.49) | 29.78 (29.60–29.98) | 40.66 (40.49–40.82) | 72.51 ± 10.50 | 73.90 ± 10.46 | 73.05 ± 10.50 |
CI = confidence interval; SD = standard deviation.
The incidence rate is reported per 100 000 person-years.